金城医药(300233.SZ)子公司获得谷胱甘肽原料药欧洲药典适用性证书

Core Viewpoint - Jincheng Pharmaceutical (300233.SZ) announced that its wholly-owned subsidiary, Shandong Jincheng Biopharmaceutical Co., Ltd. (referred to as "Jincheng Biopharma"), has recently received the Certificate of Suitability (CEP) for glutathione active pharmaceutical ingredient from the European Directorate for the Quality of Medicines (EDQM) [1] Group 1 - The receipt of the CEP certificate indicates that the glutathione active pharmaceutical ingredient meets the European Pharmacopoeia standards [1] - This certification allows Jincheng Biopharma to sell the active pharmaceutical ingredient in the European market [1] - Obtaining the CEP certificate will assist Jincheng Biopharma in further expanding its overseas market presence and enhancing the company's competitiveness in the active pharmaceutical ingredient market [1]